Peter Buhler
Director of Finance/CFO presso VALNEVA
Patrimonio netto: 175 753 $ in data 31/03/2024
Profilo
Peter Buhler is currently the Chairman-Supervisory Board at Stallergenes AG, a Member at the Swiss Institute of Certified Accountants & Tax Consultants, and the Chief Financial Officer at Valneva SE.
Previously, he held positions such as Finance Director-EMEA Region at Logitech International SA and Logitech SA, Managing Director at Stallergenes GmbH, Manager-General Accounting & Control at Eli Lilly & Co., Head-Finance & Commercial at Merck Serono SA, Chief Financial Officer at Stallergenes SA, Chief Financial Officer at Anteis SA, Chief Financial Officer at Quotient Ltd., Group Chief Financial Officer & Head-IR at Stallergenes Greer Ltd., and Group Chief Financial Officer at Zaluvida Corporate AG.
Mr. Buhler obtained an MBA from SBS Swiss Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
VALNEVA SE
0.03% | 31/12/2023 | 44 744 ( 0.03% ) | 175 753 $ | 31/03/2024 |
Posizioni attive di Peter Buhler
| Società | Posizione | Inizio |
|---|---|---|
| VALNEVA | Director of Finance/CFO | 29/07/2021 |
Stallergenes AG
 Stallergenes AG Pharmaceuticals: OtherHealth Technology Stallergenes AG engages in the manufacture and distribution of products in the medical, diagnostic, and cosmetic fields. It specializes in the production of allergen extracts for allergen immunotherapy. The firm also offers tools for the diagnosis of allergies. The company was founded on October 28, 1996 and is headquartered in Dietlikon, Switzerland. | Chairman | - |
Swiss Institute of Certified Accountants & Tax Consultants
 Swiss Institute of Certified Accountants & Tax Consultants Miscellaneous Commercial ServicesCommercial Services Swiss Institute of Certified Accountants & Tax Consultants provides initial and continuing professional development for the accountancy and tax profession. The company was founded in 1925 and is headquartered in Zurich, Switzerland. | Corporate Officer/Principal | - |
Precedenti posizioni note di Peter Buhler
| Società | Posizione | Fine |
|---|---|---|
| QUOTIENT LIMITED | Director of Finance/CFO | 01/12/2021 |
Zaluvida Corporate AG
 Zaluvida Corporate AG BiotechnologyHealth Technology Part of Zaluvida Holdings Pte Ltd., Zaluvida Corporate AG operates as a Swiss biotechnology company. The private company is based in Zurich, Switzerland. | Director of Finance/CFO | 01/03/2019 |
| STALLERGENES GREER | Director of Finance/CFO | 01/04/2017 |
| LOGITECH INTERNATIONAL S.A. | Director of Finance/CFO | 01/01/2013 |
Anteis SA
 Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Director of Finance/CFO | 01/01/2010 |
Formazione di Peter Buhler
| SBS Swiss Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| LOGITECH INTERNATIONAL S.A. | Electronic Technology |
| VALNEVA | Health Technology |
| Aziende private | 10 |
|---|---|
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
Anteis SA
Anteis SA Medical/Nursing ServicesHealth Services Anteis SA modifies and functionalizes injectable hyaluronic acid for medical applications. The firm serves in Asthetic dermatology. The company was founded by Gilles Bos Gilles in March 2003 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
Logitech SA
 Logitech SA Electronics DistributorsDistribution Services Part of Logitech International SA, Logitech SA is a Swiss company that offers a range of award-winning products, including video conferencing solutions for small to large meeting rooms. The private company is based in Romanel-sur-Morges, Switzerland. The company's products have been recognized for their design excellence, originality, and innovation by organizations such as Red Dot, Good Design, IF, and IDA. Customers can use an online tool to configure their meeting rooms with the right video conferencing solution. | Distribution Services |
STALLERGENES GmbH
 STALLERGENES GmbH Pharmaceuticals: MajorHealth Technology Stallergenes GmbH prepares and provides pharmaceuticals for the treatment of allergies. The firm's products range from diagnostic to allergen immunotherapy. It develops allergen immunotherapy and allergen supplied with highly innovative and individually tailored solutions. The company is headquartered in Kamp-Lintfort, Germany. | Health Technology |
Swiss Institute of Certified Accountants & Tax Consultants
Swiss Institute of Certified Accountants & Tax Consultants Miscellaneous Commercial ServicesCommercial Services Swiss Institute of Certified Accountants & Tax Consultants provides initial and continuing professional development for the accountancy and tax profession. The company was founded in 1925 and is headquartered in Zurich, Switzerland. | Commercial Services |
Quotient Ltd.
 Quotient Ltd. Electronic Equipment/InstrumentsElectronic Technology Quotient Ltd. is a commercial-stage diagnostics company, which provides immunohematology products to hospitals and blood banks. Its products and services include MOSAIQ and ALBA. The firm develops, manufactures, and sells conventional reagent products to equipment manufacturers. It engages in transfusion diagnostics, which focuses on blood grouping and serological disease screening. The company was founded on January 18, 2012 and is headquartered in Eysins, Switzerland. | Electronic Technology |
Stallergenes AG
Stallergenes AG Pharmaceuticals: OtherHealth Technology Stallergenes AG engages in the manufacture and distribution of products in the medical, diagnostic, and cosmetic fields. It specializes in the production of allergen extracts for allergen immunotherapy. The firm also offers tools for the diagnosis of allergies. The company was founded on October 28, 1996 and is headquartered in Dietlikon, Switzerland. | Health Technology |
Zaluvida Corporate AG
Zaluvida Corporate AG BiotechnologyHealth Technology Part of Zaluvida Holdings Pte Ltd., Zaluvida Corporate AG operates as a Swiss biotechnology company. The private company is based in Zurich, Switzerland. | Health Technology |
Stallergenes Greer Ltd.
 Stallergenes Greer Ltd. Pharmaceuticals: MajorHealth Technology Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Peter Buhler
